Post-approval studies (Phase 4)Study completedNCT00453609
What this trial is testing
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
Who this might be right for
SchizophreniaSchizoaffective DisorderBipolar Disorder+1 more
State University of New York - Upstate Medical University 15